Renal colic
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Consistent with the following symptoms and signs: (1) Sudden onset of abdominal pain and discomfort; (2) When the attack physical examination of the affected side of the kidney area may have tenderness or percussion pain; (3) The pain may be accompanied by pallor, weakness, nausea and vomiting, sweating, etc.; (4) Digestive tract reaction (nausea and vomiting, dry mouth); (5) Perineal radiating pain; (6) Urinary irritation symptoms (frequency, urgency and pain); (7) Anorectal stimulation (frequent bowel movement, tenesmus); (8) Today hematuria (mirror or naked eyes), often after the activity; Above symptom (1), (2)is necessary condition; 2. Exclude other symptoms of lumbago that are not caused by ureterospasm; 3. The patient is conscious and has stable vital signs, and can cooperate with the treatment; 4. Voluntarily participate in this clinical trial, give informed consent and sign informed consent; 5. The patient is between 18 and 65 years old.
Exclusion criteria
Exclusion criteria: 1. Delirious, mentally ill, with other serious diseases, unable to cooperate with the treatment of the patient; 2. Women during pregnancy, pregnancy and lactation; 3. Local skin is broken or ulcerated;, with severe primary diseases of viscera and other systems, and with severe urinary tract infection in urgent need of anti-infection treatment; 4. Allergy to non-steroidal anti-inflammatory drugs, previous history of gastrointestinal bleeding or active gastric ulcer, and relevant contraindications prohibited in the drug instructions; 5. Oral history of taking calcium ion blocker and alpha blocker within 4 days before enrollment; 6. Patients with poor treatment compliance; 7. Previous patients with severe cardiovascular and cerebrovascular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset time of analgesia; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS scores at 1, 5, 10, 20, 30 and 120min before and after treatment;Efficiency;The recurrence rate; | — |
Countries
China
Contacts
Public ContactChen Chiwei
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed